PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study finds known lung cancer oncogenes ALK and ROS1 also drive colorectal cancer

Genetically targeted drugs in use for lung cancer may have colorectal cancer application, as well

2013-12-18
(Press-News.org) Contact information: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Study finds known lung cancer oncogenes ALK and ROS1 also drive colorectal cancer Genetically targeted drugs in use for lung cancer may have colorectal cancer application, as well A University of Colorado Cancer Center study published online ahead of print in the journal Molecular Cancer Research shows that ALK and ROS1 gene rearrangements known to drive subsets of lung cancer are also present in some colorectal cancers. These results imply that drugs used to target ALK and ROS1 in lung cancer may also have applications in this subset of colorectal cancer patients.

"When you have known oncogenes that are already targeted by FDA-approved drugs, it just made sense to look for these oncogenes in other cancers," says Marileila Varella Garcia, PhD, investigator at the CU Cancer Center and professor at the CU School of Medicine.

"By rethinking the way we understand cancers – as their genetic mutations and not just as the sites where they live in the body – we see that a therapy that targets a specific mutation may show benefit in treating any other cancer that shares the same mutation," says Dara Aisner, MD, PhD, investigator at the CU Cancer Center and molecular pathologist at the CU School of Medicine.

In this study, Garcia, Aisner and colleagues used the technique known as fluorescence in situ hybridization (FISH) to test for the oncogenic gene rearrangements in 236 tumor samples of colorectal cancer collected from patients enrolled in a large, Australian clinical trial. The work found one patient carrying the ALK rearrangement, confirming previous findings, and demonstrated the first finding of ROS1 as an oncogenic driver of colorectal cancer – in this case found in 2 of the 236 tumor samples.

"Even though the percentage of colorectal cancer patients with these gene rearrangements is small, the benefit to these few patients could be dramatic. It's worth the work. It's worth following this line of reasoning to its conclusion to see if colorectal cancer patients will also benefit from drugs proved effective in lung cancer," says Robert C. Doebele, MD, PhD, investigator at the CU Cancer Center and assistant professor at the CU School of Medicine.

Surprisingly, these gene alterations tended to co-exist in colorectal tumors along with other molecular alterations –tumors that were positive for ALK rearrangements were also positive for another well-defined molecular alternation known as KRAS; ROS1 mutations occurred in one specimen along with the known, oncogenic mutation, BRAF.

"Conventional wisdom is that one molecular driver alteration exists throughout all tumor cells in a specimen, and that it's mutually exclusive of other alterations. We found that neither of those axioms held true – some tumor regions had different alterations, and even more surprisingly, in some regions both alterations were seen. These findings show that you can find more than one alteration in a single specimen, and that not all cells within a single tumor are necessarily driven by the same oncogene," Aisner says.

The group writes that "identification of ALK and ROS1 oncogenes may open new therapeutic options for CRC," specifically with the class of drugs known as tyrosine-kinase inhibitors (TKIs) shown to "turn off" ALK and ROS1 gene mutations thereby killing or slowing the growth of cancer cells. For example, the drug crizotinib was approved by the FDA in 2011 to treat ALK-positive lung cancer, and this drug or others that are in development to treat ALK+ and ROS1+ cancers may have similar benefit in CRC.

"This is a case in which we have all the background science – we know that when ALK and ROS1 improperly fuse with other genes, the result can be oncogenic. We have drugs that target these oncogenes. And we even have tests to determine who has the gene rearrangements and so should benefit from these drugs. The important piece missing was finding these oncogenes in other cancers, and now we've filled in that piece in colorectal cancer," Aisner says.

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

Pfeiffer fire near Big Sur, Calif.

2013-12-18
Pfeiffer fire near Big Sur, Calif. The MODIS or Moderate Resolution Imaging Spectroradiometer instrument that flies aboard NASA's Aqua satellite captured an image of smoke and detected the heat from the Pfeiffer Fire near Big Sur, California on December 16 at ...

Significant advance reported with genetically modified poplar trees

2013-12-18
Significant advance reported with genetically modified poplar trees CORVALLIS, Ore. – Forest geneticists at Oregon State University have created genetically modified poplar trees that grow faster, have resistance to insect pests and are able to retain ...

Saving Fiji's coral reefs linked to forest conservation upstream

2013-12-18
Saving Fiji's coral reefs linked to forest conservation upstream The health of coral reefs offshore depend on the protection of forests near the sea, according to a new study by the Wildlife Conservation Society that outlines the importance of terrestrial ...

New research on diverticular disease in the December issue of Clinical Gastroenterology and Hepatology

2013-12-18
New research on diverticular disease in the December issue of Clinical Gastroenterology and Hepatology Diverticulosis, a condition that develops when pouches form in the wall of the colon, is increasing in frequency. It affects the majority of ...

Water in cells behaves in complex and intricate ways

2013-12-18
Water in cells behaves in complex and intricate ways ANN ARBOR—In a sort of biological "spooky action at a distance," water in a cell slows down in the tightest confines between proteins and develops the ability to affect other proteins much farther away, University ...

Silencing synapses

2013-12-18
Silencing synapses Hope for a pharmacological solution to cocaine addiction PITTSBURGH—Imagine kicking a cocaine addiction by simply popping a pill that alters the way your brain processes chemical addiction. New research from the University of Pittsburgh suggests ...

Hack the planet? Geoengineering research, ethics, governance explored

2013-12-18
Hack the planet? Geoengineering research, ethics, governance explored Hacking the Earth's climate to counteract global warming – a subject that elicits strong reactions from both sides – is the topic of a December special issue of the journal Climatic Change. A dozen ...

TV ads nutritionally unhealthy for kids, study finds

2013-12-18
TV ads nutritionally unhealthy for kids, study finds The nutritional value of food and drinks advertised on children's television programs is worse than food shown in ads during general air time, according to University of Illinois at Chicago ...

Supercomputers help ORNL researchers identify key molecular switch that controls cell behavior

2013-12-18
Supercomputers help ORNL researchers identify key molecular switch that controls cell behavior VIDEO: Watch the flipping conformations in a pair of phenylalanine ...

DNA motor 'walks' along nanotube, transports tiny particle

2013-12-18
DNA motor 'walks' along nanotube, transports tiny particle WEST LAFAYETTE, Ind. - Researchers have created a new type of molecular motor made of DNA and demonstrated its potential by using it to transport a nanoparticle along the length of a carbon nanotube. The design ...

LAST 30 PRESS RELEASES:

New study reveals 33% gap in transplant access for UK’s poorest children

Dysregulated epigenetic memory in early embryos offers new clues to the inheritance of polycystic ovary syndrome (PCOS)

IVF and IUI pregnancy rates remain stable across Europe, despite an increasing uptake of single embryo transfer

It takes a village: Chimpanzee babies do better when their moms have social connections

From lab to market: how renewable polymers could transform medicine

Striking increase in obesity observed among youth between 2011 and 2023

No evidence that medications trigger microscopic colitis in older adults

NYUAD researchers find link between brain growth and mental health disorders

Aging-related inflammation is not universal across human populations, new study finds

University of Oregon to create national children’s mental health center with $11 million federal grant

Rare achievement: UTA undergrad publishes research

Fact or fiction? The ADHD info dilemma

Genetic ancestry linked to risk of severe dengue

Genomes reveal the Norwegian lemming as one of the youngest mammal species

Early birds get the burn: Monash study finds early bedtimes associated with more physical activity

Groundbreaking analysis provides day-by-day insight into prehistoric plankton’s capacity for change

Southern Ocean saltier, hotter and losing ice fast as decades-long trend unexpectedly reverses

Human fishing reshaped Caribbean reef food webs, 7000-year old exposed fossilized reefs reveal

Killer whales, kind gestures: Orcas offer food to humans in the wild

Hurricane ecology research reveals critical vulnerabilities of coastal ecosystems

Montana State geologist’s Antarctic research focuses on accumulations of rare earth elements

Groundbreaking cancer therapy clinical trial with US Department of Energy’s accelerator-produced actinium-225 set to begin this summer

Tens of thousands of heart attacks and strokes could be avoided each year if cholesterol-lowering drugs were used according to guidelines

Leading cancer and metabolic disease expert Michael Karin joins Sanford Burnham Prebys

Low-intensity brain stimulation may restore neuron health in Alzheimer's disease

Four-day school week may not be best for students, review finds

Using music to explore the dynamics of emotions

How the brain supports social processing as people age

Túngara frog tadpoles that grew up in the city developed faster but ended up being smaller

Where there’s fire, there’s smoke

[Press-News.org] Study finds known lung cancer oncogenes ALK and ROS1 also drive colorectal cancer
Genetically targeted drugs in use for lung cancer may have colorectal cancer application, as well